Skip to main content
. 2020 May 14;38(6):775–780. doi: 10.1016/j.clindermatol.2020.05.003

Table 2.

Recommendations on initiation and continuation of immunosuppressants

Medication Infection status
Not infected
Infected/high suspicion
Initiation Continuation Initiation Continuation
Cyclosporine Consider delay Yes No No
Mycophenolate mofetil No Yes No No
Prednisone No Consider cessation No No
Azathioprine No Yes No No
Rituximab No Consider delay No No
Methotrexate No Yes No No
Janus kinase inhibitors (JAK) No Consider cessation No No
Biologics Consider delay Yes No No